Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study

被引：0
|
作者：
Westhovens, Rene [1 ]
van der Aa, Annegret [2 ]
Jamoul, Corinne [2 ]
Tasset, Chantal [2 ]
Harrison, Pille [2 ]
机构：
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
[2] Galapagos NV, Mechelen, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
GLPG0634/GS-6034; INHIBITOR;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
534
引用
收藏
页数：3
相关论文
共 50 条
  • [21] EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3
    Aletaha, D.
    Westhovens, R.
    Gaujoux-Viala, C.
    Adami, G.
    Matsumoto, A.
    Bird, P.
    Messina, O.
    Buch, M. H.
    Bartok, B.
    Yin, Z.
    Guo, Y.
    Hendrikx, T.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 308 - 309
  • [22] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis of FINCH 3
    Westhovens, Rene
    Aletaha, Daniel
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo
    Buch, Maya
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd
    SWISS MEDICAL WEEKLY, 2020, : 9S - 10S
  • [23] Post-Hoc Analysis Of Serious Infection Events and Selected Clinical Factors In Rheumatoid Arthritis Patients Treated With Tofacitinib
    Gomez-Reino, J. J.
    Hazra, A.
    Fosser, C.
    Menon, S.
    Zwillich, S. H.
    Riese, R.
    Krishnaswami, S.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S194 - S194
  • [24] Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
    Conaghan, Philip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Marchbank, Katie
    Edwards, Christopher J.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
  • [25] Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data
    Lee, Eun Bong
    Yamanaka, Hisashi
    Liu, Yi
    Tsai, Wen-Chan
    Chen, Connie
    Kwok, Kenneth
    Yoo, Hyun-Jeong
    Llamado, Lyndon J.
    Wang, Lisy
    Luo, Yingchun
    Sugiyama, Naonobu
    Tanaka, Yoshiya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 1094 - 1106
  • [26] Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Yamaoka, Kunihiro
    Arai, Shoko
    Toyoizumi, Shigeyuki
    DeMasi, Ryan
    Fukuma, Yuri
    Hirose, Tomohiro
    Sugiyama, Naonobu
    Zwillich, Samuel H.
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 756 - 766
  • [27] Rheumatoid Arthritis Treatment with Filgotinib: Week 132 Safety Data from a Phase 2b Open-Label Extension Study
    Kavanaugh, Arthur
    Genovese, Mark C.
    Winthrop, Kevin
    Creenwald, Maria
    Ponce, Lucia
    Sosa, Favio Enriquez
    Stanislavchuk, Mykola
    Mazur, Minodora
    Spindler, Alberto
    Cseuz, Regina
    Nikulenkova, Natalya
    Glowacka-Kulesz, Maria
    Szombati, Istvan
    Dudek, Anna
    Mozaffarian, Neelufar
    Greer, Joy
    Kunder, Rebecca
    An, Di
    Meulener, Luc
    Besuyen, Robin
    Alten, Rieke
    Westhovens, Rene
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
    Wright, G. C.
    Mysler, E.
    Chen, Y. H.
    Kinch, C.
    Yndestad, A.
    Kwok, K.
    Cadatal, M. J.
    Germino, R.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
  • [29] Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3
    Aletaha, Daniel
    Westhovens, Rene
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo Daniel
    Buch, Maya H.
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd R.
    RMD OPEN, 2021, 7 (02):
  • [30] EFFICACY OF TOFACITINIB BY BACKGROUND METHOTREXATE DOSE IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS OF POOLED DATA FROM 2 PHASE 3 TRIALS
    Kivitz, A. J.
    FitzGerald, O.
    Nash, P.
    Pang, S.
    Azevedo, V. F.
    Kudlacz, E.
    Wang, C.
    Graham, D.
    Takiya, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1575 - 1575
12345